Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2020 · 10-Q
Revenue$238.45M$238.45M+4.0% vs Q1 2019 Net Income-$8.48M-$8.48MN/M vs Q1 2019 EPS Diluted-$0.17-$0.17N/M vs Q1 2019 Gross Profit$115,906,000+39.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow$2,628,000−88.6% Free Cash Flowderived-$5,621,000N/M Margins · derivedGross margin48.6%+12.3 pt vs Q1 2019
Operating margin-5.6%−7.9 pt vs Q1 2019
Net margin-3.6%−2.3 pt vs Q1 2019
ended Jun 29, 2019 · filed Aug 6, 2019 · 38 d after period end